Intervention not reported
Cancer‐specific quality of life [ · women with advanced breast cancer
1 finding from 1 review
Intervention not reported
Anxiety and depression · women with advanced breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Service provision (patient perspective) · women with advanced breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cancer‐specific quality of life [assessed using a variety of scales, · women with primary breast cancer
The intervention may leads to lower cancer‐specific quality of life [assessed using a variety of scales, (low certainty).
1 finding from 1 review
Intervention not reported
Anxiety and depression [assessed using a variety of scales, · women with primary breast cancer
The intervention may leads to lower anxiety and depression [assessed using a variety of scales, (low certainty).
1 finding from 1 review
Intervention not reported
Service provision‐patient perspective [ · women with primary breast cancer
1 finding from 1 review
Intervention not reported
General health‐related quality of life [GHQ‐28, IES, · women with primary breast cancer
It is very uncertain whether the intervention changes general health‐related quality of life [GHQ‐28, IES, (very low certainty).
1 finding from 1 review
Intervention not reported
Cancer‐specific quality of life [EORTC QLQ‐C30, EORTC‐BR23, · women with primary breast cancer
It is very uncertain whether the intervention changes cancer‐specific quality of life [EORTC QLQ‐C30, EORTC‐BR23, (very low certainty).
1 finding from 1 review
Intervention not reported
Anxiety and Depression [HADS, STAI, · women with primary breast cancer
It is very uncertain whether the intervention changes anxiety and Depression [HADS, STAI, (very low certainty).
1 finding from 1 review
Intervention not reported
Service provision‐patient perspective · women with primary breast cancer
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
General health‐related quality of life [GHQ‐12, Mastery Scale, · women with primary breast cancer
1 finding from 1 review
Local recurrence‐free survival · health problem or population
Summary of Findings Table ‐ PBI?APBI probably leads to higher local recurrence‐free survival ‐ total (LR‐FS) compared with WBRT (moderate certainty).
1 finding from 1 review
Cosmesis · health problem or population
Summary of Findings Table ‐ PBI?APBI probably leads to higher cosmesis, physician/nurse‐reported compared with WBRT (moderate certainty).
1 finding from 1 review
Overall survival · health problem or population
Summary of Findings Table ‐ PBI?APBI showed no clear difference in overall survival compared with WBRT (high certainty).
1 finding from 1 review
Late radiotherapy toxicity (subcutaneous fibrosis) · health problem or population
Summary of Findings Table ‐ PBI?APBI probably leads to higher subcutaneous fibrosis (late RT toxicity) compared with WBRT (moderate certainty).
1 finding from 1 review
Disease‐specific survival · health problem or population
Summary of Findings Table ‐ PBI?APBI showed no clear difference in cause‐specific survival (C‐SS) compared with WBRT (moderate certainty).
1 finding from 1 review
Distant metastasis‐free survival · health problem or population
Summary of Findings Table ‐ PBI?APBI showed no clear difference in distant metastasis‐free survival (DM‐FS) compared with WBRT (moderate certainty).
1 finding from 1 review
Subsequent mastectomy · health problem or population
Summary of Findings Table ‐ PBI?APBI showed no clear difference in subsequent mastectomy compared with WBRT (high certainty).
1 finding from 1 review
Overall survival: Median length of · people with metastatic breast cancer
Capecitabine‐containing regimens showed no clear difference in overall survival (OS)median compared with chemotherapy regimens without capecitabine (high certainty).
1 finding from 1 review
pCR: hormone receptor‐positive · neoadjuvant treatment of ER‐positive vs ER‐negative breast cancer
Capecitabine‐containing regimens showed no clear difference in pCR: hormone receptor‐positive compared with non‐capecitabine‐containing regimens (moderate certainty).
1 finding from 1 review